CORC

浏览/检索结果: 共8条,第1-8条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 50
作者:  Xing, Puyuan;  Zhu, Yixiang;  Shan, Ling;  Chen, Sipeng;  Hao, Xuezhi
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China 期刊论文
2017, 卷号: 8, 期号: 50, 页码: 87442-87454
作者:  Xing, Puyuan;  Zhu, Yixiang;  Shan, Ling;  Chen, Sipeng;  Hao, Xuezhi
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type 期刊论文
2017, 卷号: 96, 期号: 9, 页码: 1477-1483
作者:  Huang, Yu;  Yang, Jianliang;  Liu, Peng;  Zhou, Shengyu;  Gui, Lin
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/04
Clinical Data from the Real World: Efficacy of Crizotinib in Chinese Patients with Advanced ALK plus Non-Small Cell Lung Cancer and Brain Metastases 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S944-S944
作者:  Wang, Shouzheng;  Xing, Puyuan;  Li, Junling;  Hao, Xuezhi;  Zhang, Tongtong
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis 期刊论文
2017, 卷号: 8, 期号: 5, 页码: 482-488
作者:  Ma, Di;  Wang, Jing;  Hao, Xuezhi;  Wang, Yan;  Hu, Xingsheng
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
A Retrospective Analysis Of Nanoparticle Albumin Bound Paclitaxel In Chinese Patients With Recurrent Advanced Non-small Cell Lung Cancer In A Single Center 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S899-S900
作者:  Zhu, Yixiang;  Xing, Puyuan;  Chen, Sipeng;  Li, Junling
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
The Clinical Efficacy and Safety of Paclitaxel Liposome on the Patients with Non-Small Cell Lung Cancer: A Meta-Analysis 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S902-S902
作者:  Hu, Xingsheng;  Lin, Lin;  Xing, Puyuan;  Zhang, Changgong;  Wang, Lin
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer 期刊论文
2017, 卷号: 35, 期号: 27, 页码: 3105-+
作者:  Ma Fei;  Li Qiao;  Chen Shanshan;  Zhu Wenjie;  Fan Ying
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace